Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Moderna

Moderna Begins First Human Trial of a Vaccine for the Ebola Strain Driving Congo's Outbreak

Moderna started a phase 1 trial of an mRNA vaccine against Bundibugyo ebolavirus, a strain for which no vaccine is approved, that is driving an outbreak in Congo.

Medical Daily

The First mRNA Flu Vaccine Is Approved, and What Changes for Patients Is Not Simply Another Shot Option

The FDA approved mFlusiva for adults 50 and older. Here is who qualifies, how mRNA flu shots differ, and what still stands before they become widely available.

Medical Daily

FDA Approves First mRNA Flu Shot for Adults 50 and Older Ahead of the 2026–2027 Season

FDA approved mFLUSIVA, the first mRNA flu vaccine, for adults 50 and older. Here is what it means for fall shots, timing, and access.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

First mRNA flu shot approved by FDA bodes well for improving drugs of the future – though a few hurdles remain before mRNA can move beyond vaccines

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing processes and facilities for each vaccine candidate, and the scientific knowledge gained from one vaccine was often…

The Conversation

MRNA Stock Gets a Shot in the Arm as FDA Approves Moderna Flu Vaccine

Moderna has secured FDA approval for its flu vaccine mFLUSIVA. But does that warrant buying MRNA shares today? Let’s find out!

Barchart

FDA approves first mRNA vaccine for seasonal flu

The Food and Drug Administration's approval of an mRNA vaccine for flu comes after the agency initially refused to review the approval request for the shot.

LiveScience

First mRNA-based flu shot approved in US - despite RFK Jr’s objections to the science

Health Secretary Robert F. Kennedy Jr pulled $500 million in funding for mRNA vaccine development last year - the medical community said the U.S. would pay the price in dollars and lives

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

New kind of flu shot is on the way as the FDA approves Moderna's mRNA-based vaccine

The Food and Drug Administration has approved a new flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic

The Independent UK

Moderna starts human trials for Bundibugyo Ebola vaccine as Congo's outbreak continues

Moderna has vaccinated the first participants in a trial for a Bundibugyo Ebola vaccine, as the Democratic Republic of Congo continues to battle its fastest-growing outbreak on record.

Euronews

Moderna Says Its Norovirus Vaccine Missed an Early Success Threshold, and the Trial Will Continue

Moderna's norovirus vaccine did not meet interim success criteria in phase 3. The trial continues blinded with a new cohort. Here is what that means.

Medical Daily

Are Wall Street Analysts Predicting Moderna Stock Will Climb or Sink?

Despite Moderna's stellar outperformance over the past year, Wall Street analysts remain cautious about the stock's longer-term prospects.

Barchart

The First Vaccine Built for This Ebola Strain Has Entered Human Testing as the DRC Outbreak Becomes the Country's Largest

Oxford launched the first Phase 1 trial of a Bundibugyo Ebola vaccine. Licensed Ebola vaccines target a different species and do not cover this strain.

Medical Daily

Earnings Preview: What To Expect From Moderna’s Report

Moderna is likely to announce its fiscal second-quarter earnings by the end of this month, and analysts expect its losses to narrow.

Barchart

Short Squeeze Alert—Moderna Stock Surges on New Strategy

Moderna shares rose nearly 20% after Science Day, driven partly by a short squeeze, while its mRNA pipeline beyond vaccines faces a multi-year path to revenue.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

MRNA Stock Spikes as Moderna Shares mRNA Pipeline Update

Moderna stock soars on positive updates during the Science Day presentation. Jefferies sees significant further upside in MRNA shares.

Kiplinger

Stocks Struggle After OpenAI IPO Blow: Stock Market Today

Stocks took an early hit on news that ChatGPT parent OpenAI might push its public offering to 2027, and a midday recovery faded into the close.

The Economic Times

US stocks: US market ends lower as tech stocks weigh on sentiment

Wall Street ended lower on Friday, with AI chip stocks experiencing a significant downturn while Moderna and other healthcare companies surged. Investors are weighing the long-term potential of AI against concerns about the substantial investment required for data centers. Inflationary pressures, fueled by energy prices and chip costs, remain a…

Medical Daily

FDA Panel Backs Moderna's First mRNA Flu Shot — What It Could Mean for Your Fall Vaccine

FDA advisers unanimously backed Moderna's mRNA flu vaccine mFlusiva on June 18. Here's what the 9-0 vote means for fall 2026 vaccination and who it would cover.

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

FDA panel backs first-of-its-kind flu vaccine using mRNA technology

A new kind of flu vaccine is moving a step closer to the U.S. market

Medical Daily

FDA Advisory Panel Votes Today on First mRNA Flu Vaccine as MFLUSIVA Phase 3 Results Face Intense Scrutiny

FDA VRBPAC votes June 18 on Moderna's MFLUSIVA — the first mRNA flu vaccine. Phase 3 showed 26.6% RVE vs. standard dose; 47.9% vs. healthcare outcomes. PDUFA August 5, 2026.

AAP

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

U.S. health advisers are debating a new kind of flu vaccine

The Independent UK

New mRNA flu vaccine faces scrutiny ahead of key FDA decision

U.S. health advisers are debating a new kind of flu vaccine

Euronews

‘I worry deeply about bioterrorism’: Is Europe sufficiently prepared for another pandemic?

Internationally renowned for their life-saving Covid vaccine, what is Moderna doing now? Their CEO joins us in the studio to discuss bioterrorism, pandemic preparedness and cancer treatment.

LiveScience

3 new Ebola vaccines are being fast-tracked amid the current outbreak — when could they be ready?

The Bundibugyo virus driving the current Ebola outbreak has no approved vaccine, but researchers are leveraging decades of vaccine innovation in an effort to change that.

The Independent UK

Oxford University and Moderna to trial pioneering cancer vaccine

IN FULL

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

the Democratic Republic of Congo

301 stories

Bundibugyo

97 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.